Transpara
by Screenpoint Medical B.V. 2 variants
510(k) K181704
Active
Valid until
No date given
FDA recalls
None found
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK181704 | Date21 Nov 2018 | StatusActive |
| European Union | CE/MDD EUDAMED | Number— | Date— | StatusActive |
| European Union | CE/MDR EUDAMED | Number— | Date— | StatusActive |
Official records
From the FDA record
- Received by the FDA
- 27 Jun 2018
- FDA decision
- 21 Nov 2018 (Substantially Equivalent)
- FDA review time
- 147 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Across registries
- FDA 510(k) K181704 decided 21 Nov 2018 Active
- EUDAMED Active
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA product code
- QDQ
- Device class
- Class II
- Regulation
- 21 CFR Part 892.2090
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
Transpara is a Class II radiological computer-assisted detection and diagnosis software designed to identify lesions suspicious for cancer in imaging studies. It leverages advanced algorithms to enhance radiologist workflow by flagging potential abnormalities in mammograms, CT scans, and other radiographic modalities for further evaluation.
The software is supplied as a digital tool integrated into radiology workstations and requires no physical storage or sterilisation. It operates in MRI-safe environments and is intended for single-use per imaging session, though the underlying software license may allow repeated use across multiple studies. Authorised under FDA 510(k) clearance, MDD, and MDR compliance, it adheres to regulatory standards for diagnostic imaging software in radiology settings.
Devices cleared under K181704
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| Transpara 1.3.y | 1.3.y | 08719326450100 | — | On the market |
Similar devices
Other devices filed under FDA product code QDQ (Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer).
- Saige-Dx by DEEPHEALTH
- BU-CAD by TaiHao Medical Inc.
- Lunit INSIGHT DBT v1.1 by Lunit Inc.
- MammoScreen® (4) by Therapixel
- qCT Lung (v1.0) by Qure.Ai Technologies Pvt., Ltd.
- Genius AI Detection 2.0 by Hologic, Inc.
- Median LCS (internal name) / eyonis LCS (trade name) (1.0) by Median Technologies
- Saige-Dx (3.1.0) by DEEPHEALTH
- MammoScreen® (5) by THERAPIXEL SA
- DeepHealth ProstateAI by Quantib B.V.